• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 822


Intended Use: For use as an ingredient in a variety of food categories, excluding infant formula and foods under the jurisdiction of USDA, at levels ranging from 0.5 to 100 mg/100g.
Basis: Scientific procedures
Notifier: Laurus Labs Private Ltd.
Notifier Address: 2nd Floor, Serene Chambers Road No: 7
Banjara Hills, Hyderabad 500 034, Telangana
GRAS Notice (releasable information): GRN 822 (in PDF) (4.8 MB)
Date of closure: Jun 4, 2019
FDA's Letter: FDA has no questions (in PDF) (861 kB)